# Levothyroxine sodium

NDC: 50090-7526
Generic name: Levothyroxine sodium
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220921

FDA application: ANDA207588

## Active ingredients

- LEVOTHYROXINE SODIUM: 112 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-7526"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-7526
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ff5ad8e-f28c-4322-be6e-072487878c12